Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Quality can range from excellent to poor, making independent testing even more important with international sources
10.1056/NEJMoa2032183 63 WilliamsD
Semaglutide GLP-1 is a once-weekly injectable medication that can aid in managing chronic weight in adults, especially those with obesity or overweight individuals with at least one weight-related comorbidity like high blood pressure, high cholesterol, or type 2 diabetes
This support can help you stay on track with your medication and work up to higher doses if needed
The number of beneficiaries eligible for the Medicare GLP-1 Bridge is unknown, but a previous KFF analysis estimated that close to 14 million Medicare beneficiaries had a diagnosis of overweight or obesity in 2020 (BMI of 25-29.9 and 30 or more, respectively), though applying the specific criteria that determine eligibility for the Medicare GLP-1 Bridge would reduce that number
To schedule a virtual consultation, visit the telehealth platform, create an account, and select a time that works for you
